Dogwood Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Dogwood Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Dogwood Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $2.28M, a 56.5% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$2.28M	-$2.97M	-56.5%	Sep 30, 2024	10-Q	2024-11-08
Q2 2024	$3.64M	-$1.58M	-30.2%	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	$3.22M	-$3.3M	-50.5%	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$4.17M	-$4.2M	-50.2%	Dec 31, 2023	10-Q	2024-11-08
Q3 2023	$5.25M	-$5.61M	-51.7%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$5.21M	-$3.83M	-42.3%	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$6.52M	-$6.03M	-48%	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$8.37M	-$7.41M	-46.9%	Dec 31, 2022	10-K/A	2024-03-08
Q3 2022	$10.9M	-$9.25M	-46%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$9.04M	-$14.7M	-62%	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$12.5M	-$15.7M	-55.6%	Mar 31, 2022	10-Q	2022-05-13
Q4 2021	$15.8M	-$15.7M	-49.9%	Dec 31, 2021	10-K	2023-03-14
Q3 2021	$20.1M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$23.8M			Jun 30, 2021	10-Q	2021-08-13
Q1 2021	$28.3M			Mar 31, 2021	10-Q	2021-05-14
Q4 2020	$31.5M			Dec 31, 2020	10-K	2022-03-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.